These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Simplifying drug regimens.
    Journal: HIV Hotline; 1998 Mar; 8(1):11. PubMed ID: 11365353.
    Abstract:
    In an attempt to simplify antiretroviral regimens, several studies evaluated the use of either indinavir or nelfinavir in twice-daily dosing regimens. Results from a study testing nelfinavir at 750 mg and 1250 mg dosing levels are presented indicating some success with twice-daily therapy, particularly at the 1250 mg level. The indinavir study also shows successful viral load drops using twice-daily regimens. A twice-daily regimen might be considered for patients unable or unwilling to adhere to the thrice-daily regimen. However, long term follow-up studies are needed before switching to twice-daily therapy.
    [Abstract] [Full Text] [Related] [New Search]